The Journal of Immunology, Vol 136, Issue 9 3172-3179, Copyright © 1986 by American Association of Immunologists

ARTICLES

Immunosuppressive effects of glycosylation inhibiting factor on the IgE and IgG antibody response

M Akasaki, P Jardieu and K Ishizaka

Glycosylation inhibiting factor (GIF) was purified from culture filtrates of a T cell hybridoma, 23A4, by affinity chromatography on anti-lipomodulin Sepharose. The factor exhibited phospholipase inhibitory activity upon dephosphorylation. Immunization of BDF1 mice with aluminum hydroxide gel (alum)-absorbed dinitrophenyl derivatives of ovalbumin (DNP-OA) resulted in persistent IgE and IgG antibody formation. However, repeated injections of the affinity-purified GIF into the DNP-OA-primed mice beginning on the day of priming prevented the primary anti-hapten antibody responses of both the IgE and the IgG1 isotypes. Treatment with GIF also diminished on-going IgE antibody formation in the DNP-OA-primed mice. The treatment changed the nature of IgE-binding factors formed by BDF1 spleen cells. Incubation of spleen cells from OA + alum-primed mice with OA resulted in the formation of IgE-potentiating factor, whereas spleen cells of OA- primed, GIF-treated mice formed IgE-suppressive factor upon antigenic stimulation. It was also found that Lyt-2+ T cells in the OA-primed, GIF-treated mouse spleen cells released GIF, which had affinity for OA and bore I-Jb determinant(s). Transfer of a Lyt-1+ cell-depleted fraction of the OA-primed, GIF-treated mouse spleen cells into naive syngeneic animals resulted in suppression of the primary anti-DNP IgE antibody response of the recipients to alum-absorbed DNP-OA, but failed to affect the anti-DNP antibody response to DNP-keyhole limpet hemocyanin. The results indicate that GIF treatment during the primary response to OA facilitated the generation of antigen-specific suppressor T cells.

This article has been cited by other articles:

				K. Sugie and J. Huang GIF Inhibits Th Effector Generation by Acting on Antigen-Presenting B Cells J. Immunol., April 1, 2001; 166(7): 4473 - 4480. [Abstract] [Full Text] [PDF]

				K. Sugie, T. Tomura, K. Takakura, T. Kawano, M. Taniguchi, H. M. Grey, and K. Ishizaka Target cells for an immunosuppressive cytokine, glycosylation-inhibiting factor Int. Immunol., July 1, 1999; 11(7): 1149 - 1156. [Abstract] [Full Text] [PDF]

				T. Tomura, H. Watarai, N. Honma, M. Sato, A. Iwamatsu, Y. Kato, R. Kuroki, T. Nakano, T. Mikayama, and K. Ishizaka Immunosuppressive Activities of Recombinant Glycosylation -Inhibiting Factor Mutants J. Immunol., January 1, 1999; 162(1): 195 - 202. [Abstract] [Full Text] [PDF]

				H. Watarai, R. Nozawa, A. Tokunaga, N. Yuyama, M. Tomas, A. Hinohara, K. Ishizaka, and Y. Ishii Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF PNAS, November 21, 2000; 97(24): 13251 - 13256. [Abstract] [Full Text] [PDF]